<?xml version="1.0"?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "http://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Exp Med</journal-id>
      <journal-title>The Journal of Experimental Medicine</journal-title>
      <issn pub-type="ppub">0022-1007</issn>
      <issn pub-type="epub">1540-9538</issn>
      <publisher>
        <publisher-name>The Rockefeller University Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">9625770</article-id>
      <article-id pub-id-type="pmc">2212359</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Definitive Reports</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Human Toll Signaling Pathway: Divergence of Nuclear Factor ?B and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) </article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Muzio</surname>
            <given-names>Marta</given-names>
          </name>
          <xref ref-type="aff" rid="N0x424f530N0x451ee58">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Natoli</surname>
            <given-names>Gioacchino</given-names>
          </name>
          <xref ref-type="aff" rid="N0x424f530N0x451ee58">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saccani</surname>
            <given-names>Simona</given-names>
          </name>
          <xref ref-type="aff" rid="N0x424f530N0x451ee58">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Levrero</surname>
            <given-names>Massimo</given-names>
          </name>
          <xref ref-type="aff" rid="N0x424f530N0x451ee58">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mantovani</surname>
            <given-names>Alberto</given-names>
          </name>
          <xref ref-type="aff" rid="N0x424f530N0x451ee58">*</xref>
          <xref ref-type="aff" rid="N0x424f530N0x451ee58">&#xA7;</xref>
        </contrib>
      </contrib-group>
      <aff id="N0x424f530N0x451ee58">From the <label>*</label>Department of Immunology and Cell Biology, Mario Negri Institute, I-20157 Milan,  Italy; <label>&#x2021;</label>Istituto di I Clinica Medica, Policlinico Umberto I, I-00161 Rome, Italy; and <label>&#xA7;</label>Department of  Biotechnology, University of Brescia, 25123 Brescia, Italy</aff>
      <author-notes>
        <fn>
          <p>Address correspondence to Marta Muzio, Dept. Immunology and Cell Biology, Mario Negri Institute, via  Eritrea 62, I-20157, Milano, Italy. Phone: 39-2-39014532; Fax: 39-2-3546277; E-mail: <email>muziom@irfmn.mnegri.it</email></p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>15</day>
        <month>6</month>
        <year>1998</year>
      </pub-date>
      <volume>187</volume>
      <issue>12</issue>
      <fpage>2097</fpage>
      <lpage>2101</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>2</month>
          <year>1998</year>
        </date>
        <date date-type="rev-recd">
          <day>9</day>
          <month>4</month>
          <year>1998</year>
        </date>
      </history>
      <copyright-year>1998</copyright-year>
      <abstract>
        <p>The human homologue of <italic>Drosophila</italic> Toll (hToll) is a recently cloned receptor of the interleukin 1 receptor (IL-1R) superfamily, and has been implicated in the activation of adaptive immunity. Signaling by hToll is shown to occur through sequential recruitment of the adapter  molecule MyD88 and the IL-1R&#x2013;associated kinase. Tumor necrosis factor receptor&#x2013;activated  factor 6 (TRAF6) and the nuclear factor &#x3BA;B (NF-&#x3BA;B)&#x2013;inducing kinase (NIK) are both involved in subsequent steps of NF-&#x3BA;B activation. Conversely, a dominant negative version of  TRAF6 failed to block hToll-induced activation of stress-activated protein kinase/c-Jun NH<sub>2</sub>-terminal kinases, thus suggesting an early divergence of the two pathways.</p>
      </abstract>
      <kwd-group>
        <kwd>Toll</kwd>
        <kwd>interleukin 1 receptor</kwd>
        <kwd>nuclear factor &#x3BA;B</kwd>
        <kwd>c-Jun NH<sub>2</sub>-terminal kinase/ stress-activated protein kinase</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Immune response to infection requires the production of cytokines and costimulatory molecules by antigen-presenting  cells. Distinct cell-associated receptors on myelomonocytic  cells, such as CD14, allow the recognition of pathogen-associated molecules and trigger natural immune response  by inducing the production of inflammatory cytokines that  subsequently signal to activate adaptive immunity (<xref ref-type="bibr" rid="B1">1</xref>).</p>
    <p>The molecular mechanisms that control the initial induction of these signals upon infection have been explored  recently. In particular, a novel transmembrane receptor homologous to the <italic>Drosophila</italic> Toll, human Toll (hToll, also  called TLR4), has been cloned recently (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). The <italic>Drosophila</italic> Toll protein controls the potent antifungal response in  <italic>Drosophila</italic> adults (<xref ref-type="bibr" rid="B4">4</xref>). Analogously, hToll has been shown to  signal activation of adaptive immunity in humans by inducing the expression of B7.1, IL-6, and IL-8; thus, it represents a key molecule for the switching from natural to acquired immunity. However, the biochemical transduction  pathway triggered by hToll was ill-defined (<xref ref-type="bibr" rid="B2">2</xref>).</p>
    <p>hToll is a type I orphan receptor with an extracellular  portion containing leucine-rich repeats, and a cytoplasmic  domain significantly similar to the intracellular portion of  the IL-1R type I (IL-1RI) and the IL-1R accessory protein  (IL-1RAcP) (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>); these observations suggest that they  may use an analogous molecular framework for signaling.</p>
    <p>IL-1 triggers the activation of distinct transcription factors, including NF-&#x3BA;B and c-Jun/activator protein 1, that  subsequently drive the transcriptional induction of several  cytokine genes (<xref ref-type="bibr" rid="B7">7</xref>). The molecular events occurring from  the IL-1R signaling complex to the induction of NF-&#x3BA;B  activity have been characterized recently; in particular, the  adapter protein MyD88 recruits two distinct putative Ser/ Thr kinases, namely IL-1R&#x2013;associated kinase (IRAK) and  IRAK-2, to the receptor complex (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>). IRAK and  IRAK-2 interact subsequently with the adapter molecule  TNFR-activated factor (TRAF) 6, which bridges them to  the protein kinase NF-&#x3BA;B&#x2013;inducing kinase (NIK) (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B11">11</xref>,  <xref ref-type="bibr" rid="B12">12</xref>). Finally, NIK activates the I-&#x3BA;B kinase complex (including IKK&#x3B1; and IKK&#x3B2;) that directly phosphorylates  I-&#x3BA;B&#x3B1; (<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>).</p>
    <p>In this study, we identified and molecularly ordered the  mediators of the hToll-induced NF-&#x3BA;B and stress-activated  protein kinase (SAPK)/c-Jun NH<sub>2</sub>-terminal kinase (JNK)  activation cascade.</p>
    <sec id="MaterialsMethods" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec disp-level="3">
        <title>Expression Vectors and Transfection.</title>
        <p>TRAF6-Flag, &#x394;TRAF6-Flag (or TRAF6 298&#x2013;522), &#x394;TRAF2&#x2013;Flag (or TRAF2 87&#x2013;501),  MyD88-AU1, &#x394;MyD88-AU1 (or MyD88 152&#x2013;296), IRAK,  NIK(KK-AA), and HA-p46SAPK&#x3B3;-pCDNA3 expression vectors  have been described (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B18">18</xref>). Expression vectors for NH<sub>2</sub>-terminal  Flag-tagged hToll and &#x394;hToll (amino acids 1&#x2013;666) were constructed by inserting PCR-generated cDNA fragments lacking  the coding sequence for the signal peptide, into the mammalian  expression vector pFlag-CMV-1 (<named-content content-type="company" xlink:href="kodak">Eastman Kodak Co.</named-content>, Rochester, NY). CD4/Toll has been described previously (<xref ref-type="bibr" rid="B2">2</xref>).</p>
        <p>Human embryonic 293 or 293T cells were transiently transfected by the calcium phosphate method with the indicated plasmids. The total amount of DNA was kept constant by supplementation with an empty vector (pCDNA3; Invitrogen Corp.,  Carlsbad, CA).</p>
      </sec>
      <sec disp-level="3">
        <title>Northern Blotting Analysis.</title>
        <p>Monocytes were separated from  fresh blood of healthy donors as described previously (<xref ref-type="bibr" rid="B19">19</xref>). Total  RNA was isolated and analyzed as described previously (<xref ref-type="bibr" rid="B19">19</xref>).</p>
      </sec>
      <sec disp-level="3">
        <title>Coimmunoprecipitation Analysis.</title>
        <p>24&#x2013;36 h after transfection,  cells were lysed in 0.5 ml buffer (1% NP-40, 150 mM NaCl, 50  mM Tris, 1 mM EDTA, and protease inhibitor cocktail). Cell lysates were adjusted to 0.7 M NaCl, and the indicated antibodies  were added for 1&#x2013;4 h at 4&#xB0;C. Immune complexes were precipitated by the addition of protein G&#x2013;Sepharose (<named-content content-type="company" xlink:href="sigma">Sigma Chemical Co.</named-content>,  St. Louis, MO). After extensive washing (in lysis buffer with the  addition of 0.1% SDS), the Sepharose beads were boiled in sample buffer, and eluted proteins were fractionated by SDS-PAGE.  Subsequent immunoblotting was performed as described (<xref ref-type="bibr" rid="B8">8</xref>).</p>
      </sec>
      <sec disp-level="3">
        <title>NF-&#x3BA;B Activation Assay.</title>
        <p>Cells were transfected with endothelial leukocyte adhesion molecule&#x2013;Luciferase reporter plasmid  (NF-&#x3BA;B luc; 0.1 &#x3BC;g), pCMV-&#x3B2;-galactosidase (&#x3B2;Gal; 0.2 &#x3BC;g), and  the indicated expression vectors. Relative NF-&#x3BA;B activity was  calculated by normalizing relative luciferase activity with &#x3B2;Gal  activity as described previously (<xref ref-type="bibr" rid="B8">8</xref>). Data shown are from one out  of two to five independent experiments with similar qualitative  results. Data from experiments performed in duplicate or triplicate are expressed as mean &#xB1; SE.</p>
      </sec>
      <sec disp-level="3">
        <title>SAPK/JNK Activation Assay.</title>
        <p>Cells were transfected with  NF-&#x3BA;B luc (0.5 &#x3BC;g), HA-p46SAPK&#x3B3;-pCDNA3 (2 &#x3BC;g), and the  indicated expression vectors. 48 h after transfection, cells were  lysed in RIPA buffer containing 0.5 mM dithiothreitol, 20 mM  &#x3B2;-glycerophosphate, 1 mM sodium orthovanadate, 10 mM sodium fluoride, 1 mM PMSF, leupeptin (20 &#x3BC;g/ml), and aprotinin  (20 &#x3BC;g/ml). Lysates were cleared by centrifugation, and protein  concentration was measured using a commercial Bradford protein  assay (<named-content content-type="company" xlink:href="promega">Promega Corp.</named-content>, Madison, WI). Equal amounts of each lysate (usually 500 &#x3BC;g) were incubated on ice with 2 &#x3BC;g antiserum  to HA (rabbit polyclonal; <named-content content-type="company" xlink:href="sbct">Santa Cruz Biotechnology, Inc.</named-content>, Santa  Cruz, CA) for 2 h at 4&#xB0;C. Immune complexes were collected by  protein A&#x2013;Sepharose for 20 min and washed four times with  RIPA buffer. Precipitates were boiled in sample buffer and run  onto an SDS-polyacrylamide gel. Finally, immunoblotting was  performed to detect the active phosphorylated form of SAPK  (pThr-183/pTyr-185 of hJNK1), or SAPK as a control, by using  specific antibodies (anti-pJNK mouse monoclonal, and anti-HA;  <named-content content-type="company" xlink:href="sbct">Santa Cruz Biotechnology, Inc.</named-content>). An aliquot of the cell lysate was  also analyzed for NF-&#x3BA;B activation as above.</p>
      </sec>
    </sec>
    <sec id="ResultsDiscussion">
      <title>Results and Discussion</title>
      <p>The expression and eventual regulation of specific transcripts encoding for hToll were analyzed in distinct cell  types that play a critical role in the natural immune response. In particular, human monocytes were separated from  healthy donors and treated with the bacterial product LPS  for different periods of time. As shown in Fig. <xref ref-type="fig" rid="F1">1</xref> <italic>A</italic>, specific  transcripts for hToll were present in these cells and were  induced significantly after treatment with LPS. These observations suggest that modulation of a nonclonal receptor,  namely hToll, after exposure to infectious agents may play  a regulatory role in the natural immune response. Of note,  PMN and dendritic cells also transcribed hToll mRNA at  different levels (our unpublished observations). </p>
      <p>We next analyzed the hToll signaling pathway at the molecular level. A chimeric version of hToll in which the extra  cellular portion was substituted with the corresponding region of CD4 (CD4/hToll) has been shown previously to induce NF-&#x3BA;B activation in Jurkat cells (<xref ref-type="bibr" rid="B2">2</xref>). We engineered  distinct expression constructs encoding for Flag epitope&#x2013; tagged hToll (hToll-Flag) or for a truncated version of hToll  that lacks most of the cytoplasmic portion (&#x394;hToll-Flag).  Ectopic expression of hToll-Flag but not &#x394;hToll-Flag induced NF-&#x3BA;B activation in human embryonic 293T cells at  levels similar to the CD4/Toll chimeric protein that served  as a positive control (Fig. <xref ref-type="fig" rid="F1">1</xref>, <italic>B</italic> and <italic>C</italic>). From these observations, it is apparent that either CD4-driven or ectopic expression&#x2013;forced aggregation of the cytoplasmic portions of  distinct hToll receptors is sufficient to trigger a signaling cascade that leads ultimately to activation of the transcription  factor NF-&#x3BA;B. Given this, one could speculate that an as yet  unidentified hToll ligand binds to hToll and induces its oligomerization and subsequent signaling cascade, in a manner  similar to IL-1 and TNF with their cognate receptors.</p>
      <p>hToll shares significant sequence similarity with distinct  members of the IL-1R family, including IL-1RI, IL-1RAcP,  and MyD88; of note, Phe 513 and Trp 514 in IL-1RI, which  are conserved in all of these proteins, have been shown to  be essential for IL-1RI to signal (Fig. <xref ref-type="fig" rid="F2">2</xref> <italic>A</italic>) (<xref ref-type="bibr" rid="B20">20</xref>). Since we  have shown recently a homophilic interaction to occur between the IL-1RAcP and MyD88 throughout their homologous domains (<xref ref-type="bibr" rid="B8">8</xref>), we asked whether hToll and the  adapter protein MyD88 could interact. Upon coexpression,  MyD88 and hToll formed an immunoprecipitable complex; in contrast, a mutant version of hToll, which lacks the  region of homology to MyD88 and which was unable to  induce NF-&#x3BA;B activation, failed to bind MyD88 (Fig. <xref ref-type="fig" rid="F2">2</xref> <italic>B</italic>). </p>
      <p>A mutant version of MyD88 (&#x394;MyD88), encoding only  for the COOH-terminal IL-1R&#x2013;like domain, abrogates IL-1RI/IL-1RAcP&#x2013;induced NF-&#x3BA;B activation (<xref ref-type="bibr" rid="B8">8</xref>); given this,  we analyzed whether &#x394;MyD88 could act as a dominant  negative inhibitor of hToll-induced NF-&#x3BA;B activation. As  predicted, &#x394;MyD88 specifically inhibited hToll-induced  but not TNFR-2&#x2013;induced NF-&#x3BA;B activity, lending functional credence to the interaction occurring between hToll  and MyD88 (Fig. <xref ref-type="fig" rid="F2">2</xref> <italic>C</italic>). From these observations, it is apparent that both IL-1R and hToll recruit the adapter protein MyD88 to their respective signaling complex.</p>
      <p>IRAK and IRAK-2 are two additional proximal mediators of the IL-1R signaling complex; IRAK is recruited to  the IL-1RAcP, whereas IRAK-2 preferentially binds IL-1RI (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Given this, we asked whether IRAK or  IRAK-2 could interact with hToll. Upon ectopic expression, IRAK and hToll formed an immunoprecipitable  complex. In contrast, IRAK-2 bound only weakly to hToll  compared with IL-1RI (Fig. <xref ref-type="fig" rid="F3">3</xref>, <italic>A</italic> and <italic>B</italic>), thus suggesting  that it may not represent a relevant hToll signal transducer. </p>
      <p>NF-&#x3BA;B activation induced by a number of cytokine receptors is mediated by members of the TRAF adapter family. TRAF2, for example, plays a critical role in NF-&#x3BA;B activation mediated by TNFR-1 and TNFR-2 (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>).  TRAF6 has been implicated in the IL-1 signaling pathway  and has been shown to complex with IRAK and IRAK-2  downstream to the receptor signaling complex (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B11">11</xref>).  Therefore, we determined whether dominant negative versions of either could act to inhibit hToll-induced NF-&#x3BA;B  activity. &#x394;TRAF6 but not &#x394;TRAF2 significantly impaired  hToll-induced NF-&#x3BA;B activity, suggesting that TRAF6  may act as an additional downstream mediator of the  hToll-induced NF-&#x3BA;B activation cascade (Fig. <xref ref-type="fig" rid="F3">3</xref> <italic>C</italic>).</p>
      <p>The protein kinase NIK has been shown to act as a general mediator of TRAF-induced NF-&#x3BA;B activation (<xref ref-type="bibr" rid="B12">12</xref>);  once activated, NIK directly phosphorylates and activates  the IKK&#x3B1;/&#x3B2; complex, which is responsible for I-&#x3BA;B&#x3B1; phosphorylation and subsequent NF-&#x3BA;B activation (<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>).  Dominant negative versions of NIK, in which the critical  lysine has been mutated to alanine [NIK 429&#x2013;430 (KK-AA)], act to inhibit NF-&#x3BA;B activation induced by Fas,  TNF, and IL-1 (<xref ref-type="bibr" rid="B12">12</xref>). Given this, we asked whether  NIK(KK-AA) could inhibit hToll-induced NF-&#x3BA;B activation. NIK(KK-AA) abrogated NF-&#x3BA;B activity triggered by  hToll ectopic expression (Fig. <xref ref-type="fig" rid="F3">3</xref> <italic>C</italic>) as well as by TRAF6  overexpression (not shown).</p>
      <p>In addition to inducing activation of NF-&#x3BA;B, distinct inflammatory cytokines also induce SAPK, also known as  JNK. The active phosphorylated form of SAPK binds to  and phosphorylates the transcription factors c-Jun, activating transcription factor 2 (ATF2), and ternary complex factor (TCF)/Elk1 (<xref ref-type="bibr" rid="B23">23</xref>&#x2013;<xref ref-type="bibr" rid="B25">25</xref>). In particular, activation of SAPK/ JNK by the TNFR-1 occurs through a TRAF2-dependent  pathway, as a dominant negative version of TRAF2 acts to  inhibit both NF-&#x3BA;B and c-Jun activation induced by TNF  (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). In contrast, a dominant negative version of  NIK, which abrogates TNF-induced NF-&#x3BA;B activation,  fails to inhibit c-Jun phosphorylation, supporting a model  wherein TNF-mediated NF-&#x3BA;B and c-Jun pathways bifurcate at TRAF2 (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). Therefore, we analyzed whether  hToll induced SAPK/JNK. Ectopic expression of increasing amounts of hToll-Flag but not &#x394;hToll-Flag resulted in  activation of SAPK&#x3B3; as indicated by specific phosphorylation at Thr 183 and Tyr 185 (Fig. <xref ref-type="fig" rid="F4">4</xref> <italic>A</italic>). Overexpression of  TRAF6 also activated SAPK as described previously (<xref ref-type="bibr" rid="B28">28</xref>).  To identify mediators of hToll-mediated JNK activation, we  cotransfected 293 cells with hToll and dominant negative  versions of either MyD88 or TRAF6. Surprisingly,  &#x394;MyD88 but not &#x394;TRA6 acted to inhibit hToll-triggered  JNK phosphorylation (Fig. <xref ref-type="fig" rid="F4">4</xref> <italic>B</italic>). Importantly, under the  same experimental conditions, both &#x394;MyD88 and &#x394;TRAF6  abrogated hToll-induced NF-&#x3BA;B activation (96 and 90% inhibition, respectively). Additionally, &#x394;TRAF6 alone, as well  as &#x394;MyD88, failed to activate JNK (data not shown). Collectively, these observations indicate that although ectopic  expression of TRAF6 induced SAPK, a dominant negative  version of TRAF6 failed to inhibit hToll-induced JNK  phosphorylation. Given this, one could speculate that although TRAF6 overexpression is sufficient to activate JNK/ SAPK, endogenous TRAF6 does not provide a significant  contribution to JNK/SAPK activation by hToll (Fig. <xref ref-type="fig" rid="F5">5</xref>).  </p>
      <p>Regardless, MyD88 appears to represent the most upstream mediator of the hToll-mediated signaling cascade,  which ultimately activates NF-&#x3BA;B and c-Jun, thus driving  transcriptional activation of several cytokines and costimulatory molecules. Therefore, it may represent a potentially  useful therapeutic target for controlling the molecular  switch from the innate to the adaptive immune response.</p>
    </sec>
  </body>
  <back>
    <sec sec-type="display-objects">
      <title>Figures and Tables</title>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>hToll expression and induction of NF-&#x3BA;B.  (<italic>A</italic>) Human monocytes were treated with LPS (100 ng/ml)  for different periods of time and analyzed for their hToll  mRNA content by Northern blotting. Two distinct transcripts specific for hToll are detected and induced by LPS  stimulation. (<italic>B</italic>) Ectopic expression of hToll-Flag and  CD4/Toll but not the mutant version &#x394;hToll-Flag activate  NF-&#x3BA;B in 293T cells in a dose-dependent manner, as measured by NF-&#x3BA;B reporter gene activity. (<italic>C</italic>) Equal amounts  of hToll-Flag and &#x394;hToll-Flag are produced upon ectopic  expression in 293T cells (3.2 &#x3BC;g of each expression construct were used for this experiment). <italic>IP</italic>, Immunoprecipitation. <italic>BLOT</italic>, Immunoblotting analysis.</p>
        </caption>
        <graphic xlink:href="JEM980326.f1a"/>
        <graphic xlink:href="JEM980326.f1b"/>
        <graphic xlink:href="JEM980326.f1c"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Functional and structural evidence  of MyD88 recruitment to the hToll signaling  complex. (<italic>A</italic>) Sequence alignment of human  MyD88 (amino acids 152&#x2013;296), hToll (667&#x2013; 840), hIL-1RAcP (391&#x2013;570), and hIL-1RI  (381&#x2013;569). Alignment was performed with Clustall software. <italic>Shading</italic>, Identical amino acids with  a score &lt;3. <italic>Boxes</italic>, Identical amino acids with a  score = 0. <italic>Dots</italic>, Conserved amino acids that are  essential for IL-1RI to signal (reference <xref ref-type="bibr" rid="B20">20</xref>). (<italic>B</italic>)  MyD88 associates with hToll but not with a  truncated version of hToll (&#x394;hToll) lacking the  cytoplasmic region sharing sequence similarity  with MyD88. 293T cells were transfected with  hToll-Flag, &#x394;hToll-Flag, or IL-1RAcP&#x2013;Flag as  a positive control together with AU1-tagged  MyD88. The presence of MyD88 that coprecipitated with the receptors was detected by  immunoblotting with a rabbit polyclonal antiserum to MyD88. (<italic>C</italic>) &#x394;MyD88 inhibits hToll-induced but not the unrelated TNFR-2&#x2013;induced  NF-&#x3BA;B activity. 1 &#x3BC;g of receptors and 1.5 &#x3BC;g of  &#x394;MyD88 were transfected. Data are expressed  as the percentage of relative receptor-induced  NF-&#x3BA;B activity.</p>
        </caption>
        <graphic xlink:href="JEM980326.f2a"/>
        <graphic xlink:href="JEM980326.f2bc"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>NF-&#x3BA;B activation by hToll occurs through IRAK, TRAF6,  and NIK. (<italic>A</italic>) IRAK is recruited to hToll but not to the inactive truncated version of hToll (&#x394;hToll). IL-1RAcP served as a positive control.  Cells were transfected and analyzed as in Fig. <xref ref-type="fig" rid="F2">2</xref> <italic>B</italic>. (<italic>B</italic>) IRAK-2 binds very  weakly to hToll. IL-1RI served as a positive control. Cells were transfected and analyzed as in <italic>A</italic>. (<italic>C</italic>) &#x394;TRAF6 but not the unrelated  &#x394;TRAF2 attenuates CD4/Toll-induced NF-&#x3BA;B activity. A dominant  negative mutant version of the downstream molecule NIK [NIK(KK-AA)] also inhibits CD4/hToll-induced NF-&#x3BA;B activity.</p>
        </caption>
        <graphic xlink:href="JEM980326.f3"/>
      </fig>
      <fig position="float" id="F4">
        <label>Figure 4</label>
        <caption>
          <p>hToll-induced SAPK activation requires MyD88 but not  TRAF6. (<italic>A</italic>) hToll activates SAPK/JNK in a dose-dependent manner, as  determined by the presence of the active phosphorylated form of JNK  (pJNK). <italic>F.I.</italic>, Fold induction calculated by normalizing pJNK with JNK.  <italic>HC</italic>, IgG heavy chain. (<italic>B</italic>) MyD88 (152&#x2013;296) (&#x394;MyD88) but not TRAF6  (289&#x2013;522) (&#x394;TRAF6) abolishes hToll-induced SAPK/JNK phosphorylation. <italic>F.I.</italic>, Fold induction calculated by normalizing pJNK with JNK.  <italic>HC</italic>, IgG heavy chain.</p>
        </caption>
        <graphic xlink:href="JEM980326.f4a"/>
        <graphic xlink:href="JEM980326.f4b"/>
      </fig>
      <fig position="float" id="F5">
        <label>Figure 5</label>
        <caption>
          <p>Overview of hToll and TNFR-1 signaling pathways. The  diagram shows that the bifurcation of NF-&#x3BA;B and JNK/SAPK activation  by hToll or TNFR-1 occurs at different levels with respect to the specific  TRAFs. <italic>TRADD</italic>, TNFR-1&#x2013;associated death domain. <italic>RIP</italic>, Receptor-interacting protein.</p>
        </caption>
        <graphic xlink:href="JEM980326.f5"/>
      </fig>
    </sec>
    <ack>
      <p>We wish to thank R. Medzhitov and C.A. Janeway for CD4/Toll cDNA, James Woodgett for HA-SAPK&#x3B3;-pCDNA3, and Z. Cao for reagents and for critical reading of the manuscript.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Medzhitov</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Janeway</surname>
              <given-names>A</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Innate immunity: the virtues of a nonclonal system of recognition</article-title>
          <source>Cell</source>
          <year>1997</year>
          <volume>91</volume>
          <fpage>295</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="pmid">9363937</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Medzhitov</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Preston-Hurlburt</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Janeway</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>A human homologue of the <italic>Drosophila</italic>Toll protein signals activation of adaptive immunity</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>388</volume>
          <fpage>394</fpage>
          <lpage>397</lpage>
          <pub-id pub-id-type="pmid">9237759</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rock</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Hardiman</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Timans</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Kastelein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bazan</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>A family of human receptors structurally related  to <italic>Drosophila</italic>Toll</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1997</year>
          <volume>95</volume>
          <fpage>558</fpage>
          <lpage>592</lpage>
        </citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lemaitre</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nicolas</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Michaut</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Reichart</surname>
              <given-names>J-M</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in <italic>Drosophila</italic>adults</article-title>
          <source>Cell</source>
          <year>1996</year>
          <volume>86</volume>
          <fpage>973</fpage>
          <lpage>983</lpage>
          <pub-id pub-id-type="pmid">8808632</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenfeder</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kwee</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Labow</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chizzonite</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Ju</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex</article-title>
          <source>J Biol Chem</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>13757</fpage>
          <lpage>13765</lpage>
          <pub-id pub-id-type="pmid">7775431</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gay</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Keith</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title><italic>Drosophila</italic>Toll and IL-1 receptor</article-title>
          <source>Nature</source>
          <year>1991</year>
          <volume>351</volume>
          <fpage>355</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="pmid">1851964</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dinarello</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Biologic basis for interleukin-1 in disease</article-title>
          <source>Blood</source>
          <year>1996</year>
          <volume>87</volume>
          <fpage>2095</fpage>
          <lpage>2147</lpage>
          <pub-id pub-id-type="pmid">8630372</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muzio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ni</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dixit</surname>
              <given-names>VM</given-names>
            </name>
          </person-group>
          <article-title>IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling</article-title>
          <source>Science</source>
          <year>1997</year>
          <volume>278</volume>
          <fpage>1612</fpage>
          <lpage>1615</lpage>
          <pub-id pub-id-type="pmid">9374458</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wesche</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Henzel</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Shillinglaw</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>MyD88: an adapter that recruits IRAK to the IL-1 receptor complex</article-title>
          <source>Immunity</source>
          <year>1997</year>
          <volume>7</volume>
          <fpage>837</fpage>
          <lpage>847</lpage>
          <pub-id pub-id-type="pmid">9430229</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Henzel</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>IRAK: a kinase associated with the interleukin-1 receptor</article-title>
          <source>Science</source>
          <year>1996</year>
          <volume>271</volume>
          <fpage>1128</fpage>
          <lpage>1131</lpage>
          <pub-id pub-id-type="pmid">8599092</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kurama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Goeddel</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>TRAF6 is a signal transducer for interleukin-1</article-title>
          <source>Nature</source>
          <year>1996</year>
          <volume>383</volume>
          <fpage>443</fpage>
          <lpage>446</lpage>
          <pub-id pub-id-type="pmid">8837778</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malinin</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Boldin</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Kovalenko</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Wallach</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>MAP3K-related kinase involved in NF-&#x3BA;B induction by TNF, CD95 and IL-1</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>385</volume>
          <fpage>540</fpage>
          <lpage>544</lpage>
          <pub-id pub-id-type="pmid">9020361</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DiDonato</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Hayakawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rothwarf</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Zandi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Karin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A cytokine-responsive I&#x3BA;B kinase that activates the transcription factor NF-&#x3BA;B</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>388</volume>
          <fpage>548</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="pmid">9252186</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>R&#xE9;gnier</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Goeddel</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Rothe</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of an I&#x3BA;-B kinase</article-title>
          <source>Cell</source>
          <year>1997</year>
          <volume>90</volume>
          <fpage>373</fpage>
          <lpage>383</lpage>
          <pub-id pub-id-type="pmid">9244310</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mercurio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Shevcenko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bennet</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Manning</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>IKK-1 and IKK-2: cytokine-activated I&#x3BA;B kinases essential for NF-&#x3BA;B activation</article-title>
          <source>Science</source>
          <year>1997</year>
          <volume>278</volume>
          <fpage>860</fpage>
          <lpage>866</lpage>
          <pub-id pub-id-type="pmid">9346484</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Woronicz</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Rothe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goeddel</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>I&#x3BA;B kinase-&#x3B2;: NF-&#x3BA;B activation and complex formation with I&#x3BA;B kinase-&#x3B1; and NIK</article-title>
          <source>Science</source>
          <year>1997</year>
          <volume>278</volume>
          <fpage>866</fpage>
          <lpage>869</lpage>
          <pub-id pub-id-type="pmid">9346485</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zandi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rothwarf</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Delhase</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hayakawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Karin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The I&#x3BA;B kinase complex contains two kinase subunits, IKK&#x3B1; and IKK&#x3B2;, necessary for I&#x3BA;B phosphorylation and NF-&#x3BA;B activation</article-title>
          <source>Cell</source>
          <year>1997</year>
          <volume>91</volume>
          <fpage>243</fpage>
          <lpage>252</lpage>
          <pub-id pub-id-type="pmid">9346241</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Natoli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Costanzo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ianni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Templeton</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Woodgett</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Balsano</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Levrero</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Activation of SAPK/JNK by TNF receptor-1 through a noncytotoxic TRAF2-dependent pathway</article-title>
          <source>Science</source>
          <year>1997</year>
          <volume>275</volume>
          <fpage>200</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="pmid">8985011</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muzio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Re</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sironi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Polentarutti</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Minty</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Caput</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ferrara</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mantovani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Colotta</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells</article-title>
          <source>Blood</source>
          <year>1994</year>
          <volume>83</volume>
          <fpage>1738</fpage>
          <lpage>1743</lpage>
          <pub-id pub-id-type="pmid">7908231</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heguy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baldari</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Macchia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Telford</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Melli</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the <italic>Drosophila</italic>Toll protein are essential for IL-1R signal transduction</article-title>
          <source>J Biol Chem</source>
          <year>1992</year>
          <volume>267</volume>
          <fpage>2605</fpage>
          <lpage>2609</lpage>
          <pub-id pub-id-type="pmid">1531143</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rothe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Henzel</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Goeddel</surname>
              <given-names>DV</given-names>
            </name>
          </person-group>
          <article-title>A novel family of putative signal transducers associated with the cytoplasmic domain of the 75kDa tumor necrosis factor receptor</article-title>
          <source>Cell</source>
          <year>1994</year>
          <volume>78</volume>
          <fpage>681</fpage>
          <lpage>692</lpage>
          <pub-id pub-id-type="pmid">8069916</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rothe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sarma</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Dixit</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Goeddel</surname>
              <given-names>DV</given-names>
            </name>
          </person-group>
          <article-title>TRAF2-mediated activation of NF-&#x3BA;B by TNF receptor 2 and CD40</article-title>
          <source>Science</source>
          <year>1995</year>
          <volume>269</volume>
          <fpage>1424</fpage>
          <lpage>1427</lpage>
          <pub-id pub-id-type="pmid">7544915</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Derijard</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hibi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>I-H</given-names>
            </name>
            <name>
              <surname>Baret</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Karin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain</article-title>
          <source>Cell</source>
          <year>1994</year>
          <volume>76</volume>
          <fpage>1025</fpage>
          <lpage>1037</lpage>
          <pub-id pub-id-type="pmid">8137421</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kyriakis</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Banerjee</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nikolakaki</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rubie</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Ahmad</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Avruch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Woodgett</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>The stress-activated protein kinase subfamily of c-Jun kinases</article-title>
          <source>Nature</source>
          <year>1994</year>
          <volume>369</volume>
          <fpage>156</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="pmid">8177321</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adler</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Polotskaya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kraft</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity</article-title>
          <source>J Biol  Chem</source>
          <year>1992</year>
          <volume>267</volume>
          <fpage>17001</fpage>
          <lpage>17005</lpage>
          <pub-id pub-id-type="pmid">1324919</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reinhard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shamoon</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Shyamala</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>LT</given-names>
            </name>
          </person-group>
          <article-title>Tumor necrosis factor &#x3B1;-induced activation of c-Jun N-terminal kinase is mediated by TRAF2</article-title>
          <source>EMBO (Eur Mol  Biol Organ) J</source>
          <year>1997</year>
          <volume>16</volume>
          <fpage>1080</fpage>
          <lpage>1092</lpage>
          <pub-id pub-id-type="pmid">9118946</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Goeddel</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Karin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-&#x3BA;B activation prevents cell death</article-title>
          <source>Cell</source>
          <year>1996</year>
          <volume>87</volume>
          <fpage>565</fpage>
          <lpage>576</lpage>
          <pub-id pub-id-type="pmid">8898208</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>R&#xE9;gnier</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Kirschining</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Goeddel</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Rothe</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of NF-&#x3BA;B and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>9792</fpage>
          <lpage>9796</lpage>
          <pub-id pub-id-type="pmid">9275204</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Natoli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Costanzo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Moretti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fulco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Balsano</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Levrero</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>TNF receptor-1 signaling downstream of TRAF2</article-title>
          <source>J Biol Chem</source>
          <year>1997</year>
          <volume>272</volume>
          <fpage>26079</fpage>
          <lpage>26082</lpage>
          <pub-id pub-id-type="pmid">9334169</pub-id>
        </citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p>M. Muzio is supported by Federazione Italiana Ricerca sul Cancro. This work was supported by European  Community Special Project Biotechnology, Consiglio Nazionale Ricerche, and Associazione Italiana  Ricerca sul Cancro. </p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>
